"Mod Pathol"[jour] - Search Results

Year	Number of Results
1988	69
1989	103
1990	122
1991	128
1992	135
1993	143
1994	175
1995	167
1996	203
1997	191
1998	192
1999	167
2000	186
2001	189
2002	173
2003	171
2004	203
2005	222
2006	234
2007	193
2008	239
2009	231
2010	246
2011	237
2012	248
2013	298
2014	250
2015	178
2016	223
2017	262
2018	307
2019	309
2020	387
2021	356
2022	272
2023	273
2024	225
2025	128

1

Corrigendum to "POLE-Mutated Uterine Carcinosarcomas: A Clinicopathologic and Molecular Study of 11 Cases": [Modern Pathology 38 (2025) 100676].

Hammer PM, Momeni-Boroujeni A, Kolin DL, Kingsley L, Folkins A, Geisick RLP, Ho C, Suarez CJ, Howitt BE. Hammer PM, et al. Mod Pathol. 2025 Apr 29:100784. doi: 10.1016/j.modpat.2025.100784. Online ahead of print. Mod Pathol. 2025. PMID: 40377507 No abstract available.

2

Corrigendum to "Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical Pathologist" [Modern Pathology 38 (2025) 100752].

Jafari P, Forrest ME, Segal J, Wang P, Tjota MY. Jafari P, et al. Mod Pathol. 2025 Apr 14:100773. doi: 10.1016/j.modpat.2025.100773. Online ahead of print. Mod Pathol. 2025. PMID: 40377506 No abstract available.

3

Concordance Between the PD-L1 Tumor Area Positivity Score and Combined Positive Score for Gastric or Esophageal Cancers Treated With Tislelizumab.

Moehler M, Yoon HH, Wagner DC, Yang S, Shi J, Zhang Y, Hu H, La Placa C, Peng Y, Du W, McCampbell A, Xu W, Shen Z, Xu H, Huang R, Kato K. Moehler M, et al. Mod Pathol. 2025 May 13:100793. doi: 10.1016/j.modpat.2025.100793. Online ahead of print. Mod Pathol. 2025. PMID: 40373876

4

Malignant Chondroblastoma: An Epigenetically Distinct Subtype of Chondroblastoma with a Predilection for the Skeletally Mature.

Fritchie K, Ameline B, Andrei V, Charville G, Hornick JL, Meredith DM, John I, Michal M, Pancsa T, Kilpatrick SE, Reith J, Wang Z, Horvai A, Gross J, Sumathi V, Davis JL, Purgina B, Raymond DP, Ilaslan H, Chrisinger J, Din NU, Hung YP, Nielsen GP, Mogler C, Papke DJ, Baumhoer D. Fritchie K, et al. Mod Pathol. 2025 May 8:100790. doi: 10.1016/j.modpat.2025.100790. Online ahead of print. Mod Pathol. 2025. PMID: 40348060 Free article.

5

Comprehensive Clinicopathological and Multiomics Characterization of Dermatofibrosarcoma Protuberans Revealed PDGFD Fusion as Distinct Molecular Subtype with Better Survival.

Yeung MCF, Fong T, Liu APY, Chan RCK, Chan AZ, Lau WH, Lok J, Gao GY, Leung SY, Shek TWH. Yeung MCF, et al. Mod Pathol. 2025 May 8:100792. doi: 10.1016/j.modpat.2025.100792. Online ahead of print. Mod Pathol. 2025. PMID: 40348059

6

Differential Localization of β-catenin Protein in CTNNB1 Mutant Endometrial Cancers Results in Distinct Transcriptional Profiles.

Parrish ML, Osborne-Frazier ML, Broaddus RR, Gladden AB. Parrish ML, et al. Mod Pathol. 2025 May 8:100791. doi: 10.1016/j.modpat.2025.100791. Online ahead of print. Mod Pathol. 2025. PMID: 40348058

7

Molecular Landscape, Genomic Shift and Prediction in the Neoadjuvant Setting of HER2 Positive Breast Cancer.

Pons L, Hernandez L, Urbizu A, Arnaldo L, Rodriguez-Martinez P, Sanz C, Ma Muñoz-Mármol A, Fernandez E, Felip E, Quiroga V, Margelí M, Fernandez PL. Pons L, et al. Mod Pathol. 2025 May 6:100787. doi: 10.1016/j.modpat.2025.100787. Online ahead of print. Mod Pathol. 2025. PMID: 40340028

8

Malignant transformation in pleomorphic adenoma: the impact of DNA methylation profiling and pathogenic mutations.

Uro-Coste E, Nicaise Y, Akiki B, Decamps C, Chaltiel L, Siegfried A, Herbault-Barres B, Reboul H, Bassey E, Modesto A, Poissonnet V, Even C, Verillaud B, Costes-Martineau V, Ferrand FR, Vergez S, Cohen-Jonathan-Moyal E. Uro-Coste E, et al. Mod Pathol. 2025 Apr 29:100786. doi: 10.1016/j.modpat.2025.100786. Online ahead of print. Mod Pathol. 2025. PMID: 40311763 Free article.

9

Not All HER2-Positive Breast Cancers Are the Same: Intratumoral Heterogeneity, Low-Level HER2 Amplification, and Their Impact on Neoadjuvant Therapy Response.

Dai W, Navolotskaia O, Fine JL, Harinath L, Motanagh SA, Villatoro TM, Bhargava R, Clark BZ, Yu J. Dai W, et al. Mod Pathol. 2025 Apr 29;38(7):100785. doi: 10.1016/j.modpat.2025.100785. Online ahead of print. Mod Pathol. 2025. PMID: 40311762 Free article.

10

Incidence, Clinicopathologic Features, and Follow-Up Results of human epidermal growth factor receptor-2-Ultralow Breast Carcinoma.

Hu Y, Jones D, Zhao W, Tozbikian G, Parwani AV, Li Z. Hu Y, et al. Mod Pathol. 2025 Apr 22;38(8):100783. doi: 10.1016/j.modpat.2025.100783. Online ahead of print. Mod Pathol. 2025. PMID: 40274067 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,958 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,958 results

Results by year